Log in to save to my catalogue

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and m...

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811876544

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

About this item

Full title

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Diabetologia, 2016-09, Vol.59 (9), p.1860-1870

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Aims/hypothesis
Sodium glucose cotransporter 2 (SGLT2) inhibition lowers HbA
1c
, systolic BP (SBP) and weight in patients with type 2 diabetes and reduces renal hyperfiltration associated with type 1 diabetes, suggesting decreased intraglomerular hypertension. As lowering HbA
1c
, SBP, weight and intraglomerular pressure is associat...

Alternative Titles

Full title

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1811876544

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811876544

Other Identifiers

ISSN

0012-186X

E-ISSN

1432-0428

DOI

10.1007/s00125-016-4008-2

How to access this item